A comprehensive view of Oppenheimer Holdings Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Retail & Omnichannel Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Oppenheimer downgrades McDonald's to perform and eliminates 12-month target, citing lack of growth catalysts despite strong 2023 performance; analyst speculates waning pricing advantages, difficulties capturing market share with budget-conscious consumers
Published: January 05, 2024 by Indian Investments Abroad
Oppenheimer upgrades Moderna to outperform, says vaccine maker could bring five new medications to market by 2026; company's Covid-19 vaccine sales could rise in 2025 and beyond, as education about respiratory disease increases globally
Published: January 03, 2024 by Baystreet US News Alerts
Commentary: Strategists set optimistic outlooks for S&P 500 in 2024 following Fed indicating potential rate cuts next year; Goldman Sachs, Bank of America, BMO, Citi, Deutsche Bank, Oppenheimer, RBC among firms targeting S&P 500 to reach 5,000 or more
Published: December 19, 2023 by Finbold
Oppenheimer strategist predicts 12% upside in S&P 500 by end-2024 after Fed maintains borrowing rates, forecasts three interest rate cuts in coming year; benchmark index already on track to to close 2023 with over 20% gain
Published: December 13, 2023 by Invezz
Amazon analyst roundup: Oppenheimer names top pick going into 2024, citing exposure to affluent customers, advertising and margin expansion opportunities; D.A. Davidson maintains buy rating, encouraged by robust seasonal hiring plans of 250,000 workers
Published: October 19, 2023 by The Motley Fool

Ask us about our Retail & Omnichannel market view

Trending Chart

Interactive chart with headline count